Christal Mickle

USPTO Granted Patents = 20 (Patent Applications = 2)

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 6.4

ph-index = 10

Forward Citations = 238(Granted Patents)

Location History:

Charlottesville, VA (US) (2008)
Celebration, FL (US) (2015 - 2017)
Coralville, IA (US) (2013 - 2019)
Kissimmee, FL (US) (2018 - 2020)

Company Filing History:

Years Active: 2008-2020

Loading Chart...

20 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10870654 - Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same (2020-12-22),

2. 10849981 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof (2020-12-01),

3. 10654863 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof (2020-05-19),

4. 10577376 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof (2020-03-03),

5. 10358452 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof (2019-07-23),

6. 10351574 - Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same (2019-07-16),

7. 10351573 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof (2019-07-16),

8. 9872915 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof (2018-01-23),

9. 9650387 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof (2017-05-16),

10. 9549923 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof (2017-01-24),

11. 9132125 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof (2015-09-15),

12. 9125947 - Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof (2015-09-08),

13. 8927716 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof (2015-01-06),

14. 8871780 - Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof (2014-10-28),

15. 8828978 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof (2014-09-09),

Title: Innovator in Pain Management: Christal Mickle

Introduction

Christal Mickle, based in Kissimmee, Florida, is an accomplished inventor with an impressive portfolio of 20 patents. He has made significant contributions to the field of pharmaceutical sciences, specifically focusing on pain management and related therapies. His innovative approaches have the potential to improve patient outcomes and minimize side effects associated with traditional treatments.

Latest Patents

Among Christal Mickle's notable work are his recent patents that explore innovating compositions and processes surrounding hydrocodone benzoic acid enol ester. These include:

1. **Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same** - This patent details the creation of novel prodrugs that include various polymorphs, which can enhance the bioavailability of hydrocodone.

2. **Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof** - This technology outlines methodologies for treating patients experiencing moderate to severe pain while addressing issues related to narcotic or opioid abuse and withdrawal. The compositions described demonstrate a reduction in side effects compared to unconjugated hydrocodone.

Career Highlights

Over the course of his career, Christal has worked with reputable companies including Kempharm, Inc. and Shire LLC. His contributions have been pivotal in advancing the development of therapeutic options in the pharmaceutical industry.

Collaborations

Throughout his professional journey, Christal has collaborated with talented individuals such as Travis C Mickle and Sven Guenther, enhancing the innovation process through shared expertise and teamwork.

Conclusion

Christal Mickle continues to be a significant figure in pharmaceutical innovation, particularly in the area of pain management therapies. His commitment to developing effective and safer options for patients demonstrates his dedication to improving healthcare outcomes and showcases the importance of inventive solutions in the field.

This text is generated by artificial intelligence and may not be accurate.